4598 Delta-Fly Pharma
- 637
- +12+1.92%
Delta-Fly Pharma News
Delta-Fly Pharma: Interim report
Delta-Fly Pharma: Confirmatory letter.
Delta-Fly Pharma: Securities report - 14th period (April 01, 2023 - March 31, 2024)
DELTA FLY PHARMA: Financial results presentation materials for the fiscal year ending 2024/3 20240515
DELTA FLY PHARMA: Summary of financial results for the fiscal year ending March 31, 2024 [Japanese GAAP] (unconsolidated)
Delta-Fly Pharma: Confirmation Letter
Delta-Fly Pharma: Quarterly Report - 14th Quarter 3rd Quarter (2023/10/01 - 2023/12/31)
Delta-Fly Pharma: Supplemental financial results for the 3rd quarter of the fiscal year ending March 31, 2024
Delta-Fly Pharma: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2024 [Japanese GAAP] (unconsolidated)
Delta-Fly Pharma: (Correction) Partial correction to “Supplementary Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2024”
Delta-Fly Pharma: Confirmation letter
Delta-Fly Pharma: Quarterly Report - 14th Second Quarter (2023/07/01 - 2023/09/30)
Delta-Fly Pharma: Supplementary financial results for the 2nd quarter of the fiscal year ending March 31, 2024
Delta-Fly Pharma: Summary of Financial Results for the 2nd Quarter Ending March 2024 [Japanese GAAP] (Unconsolidated)
Delta-Fly Pharma: Extraordinary Report
Delta-Fly Pharma: Confirmation letter
Delta-Fly Pharma: Quarterly Report - 14th First Quarter (2023/04/01 - 2023/06/30)
Delta-Fly Pharma: Supplementary materials for financial results for the first quarter of the fiscal year ending March 31, 2024
Delta-Fly Pharma: Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Unconsolidated)
Delta-Fly Pharma: Extraordinary Report
Analysis
Price Target
No Data
